Agile Therapeutics, Inc. - Common Stock (NQ:AGRX)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 02, 2024

Via Benzinga

Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage Requirement

December 12, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024

November 22, 2023

Via ACCESSWIRE

Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024 ↗

November 21, 2023

Agile Therapeutics, Inc. (NASDAQ: AGRX), the commercial-stage women’s healthcare company, posted a 122% increase in third-quarter revenue year-over-year, driven by strong demand for TwirlaⓇ...

Via Benzinga

Why Shares of Agile Therapeutics Jumped This Week ↗

September 28, 2023

The women's healthcare company got an analyst upgrade.

Via The Motley Fool

Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 09, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023

October 26, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

A Look Into Healthcare Sector Value Stocks ↗

October 16, 2023

Via Benzinga

Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

October 04, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics (NASDAQ: AGRX) Upgraded To “Buy” Rating By Analysts At Maxim Group

September 28, 2023

Via ACCESSWIRE

Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group ↗

September 27, 2023

Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its research....

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

September 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 22, 2023

Via Benzinga

Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference

September 05, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗

September 22, 2023

Via Benzinga

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter

August 17, 2023

Via ACCESSWIRE

Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter ↗

August 16, 2023

On August 9, Agile Therapeutics (NASDAQ: AGRX) released its second-quarter financial results, showing significant growth in revenue from its innovative weekly bi

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

August 14, 2023

Via Benzinga

Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

August 09, 2023

From Agile Therapeutics, Inc.

Via GlobeNewswire

Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023

July 26, 2023

Live Conference Call and Webcast at 8:30 a.m. ET

From Agile Therapeutics, Inc.

Via GlobeNewswire

This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions of Women Thanks to a Partnership With Afaxys

July 19, 2023

Via ACCESSWIRE

Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women

July 18, 2023

Via ACCESSWIRE

This Reproductive Health Company's Weekly Contraceptive Patch Can Reach Millions Of Women Thanks To A Partnership With Afaxys ↗

July 17, 2023

Agile Therapeutics, Inc.’s (NASDAQ: AGRX) partnership with Afaxys Pharma is expected to play a key role in propelling the women’

Via Benzinga

Agile Therapeutics Partners With Telehealth Platforms To Expand Access To Weekly Birth Control Patch To Millions Of Women ↗

July 14, 2023

This month, Agile Therapeutics, Inc. (NASDAQ: AGRX) announced partnerships with FPA Women’s Health and

Via Benzinga

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage

July 11, 2023

Via ACCESSWIRE

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden's Latest Executive Order Expanding Contraceptive Coverage ↗

July 10, 2023

In June, President Biden issued an Executive Order on Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services.

Via Benzinga

H.C. Wainwright Reiterates Buy Rating For Agile Therapeutics (NASDAQ: AGRX), Citing Growing Demand For Twirla, A Weekly Low Dose Birth Control Patch

July 05, 2023

Via ACCESSWIRE

This Women's Healthcare Company Raised $7.5 Million In A Public Offering And Says It's Targeting $25 To $30 Million Net Revenue By End Of 2023

July 03, 2023

Via ACCESSWIRE

Why Tattooed Chef Are Trading Lower By 47%; Here Are 20 Stocks Moving Premarket ↗

July 03, 2023

Gainers Micromobility.com Inc. (NASDAQ: MCOM) shares surged 60% to $0.18 in pre-market trading. micromobility.com recently reported a strategic realignment to strengthen its financial position and...

Via Benzinga

Agile Therapeutics Expects Its Innovative Once-A-Week Birth Control Patch To Drive Revenues Of $25-30 Million In 2023 - What Is The Hype All About?

June 30, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.